400客服电话
购买数据产品
400-9696-311 转1
定制咨询业务
400-9696-311 转2
数据与AI定制业务
400-9696-311 转3
商务合作及其他问题
400-9696-311 转4
投诉及建议
400-9696-311 转5
ChiCTR2100047819
尚未开始
/
/
/
2021-06-27
/
/
乳腺癌
The Effects of Multi-modal Intervention in Managing Symptom Cluster of Cancer-Related Fatigue-Sleeping Problem-Depressed Mood in Breast Cancer Patients undergoing Chemotherapy: A Randomized Controlled Trial
The Effects of Multi-modal Intervention in Managing Symptom Cluster of Cancer-Related Fatigue-Sleeping Problem-Depressed Mood in Breast Cancer Patients undergoing Chemotherapy: A Randomized Controlled Trial
The aim of this study is to examine the effect of multi-modal intervention in managing F-S-D cluster in BC patients undergoing chemotherapy in Hong Kong. The objectives are to investigate the effect of multimodal intervention on 1. CRF 2. sleeping quality 3. depressed mood 4. QOL in BC patients undergoing chemotherapy in Hong Kong
随机平行对照
其它
All eligible participants are randomized into experimental or controls group through permuted block randomization with a block size of 4 and 6. The randomization sequence will be performed by a research assistant.
Control group will receive one education session (around 10 minutes) on the side effect of chemotherapy and their management. A paper material will be given to them. Two phones follow-up sessions (approximately 15-20 minutes in each session) will be provided to them to reinforce their knowledge on the side effects of chemotherapy and their management at week four and week seven. After completion of follow-up timepoint measurement, participants will receive the education booklet used in intervention group. All participants in control and experimental group are advised not to disclose the intervention to others.
No funding
/
59
/
2021-07-01
2022-10-31
/
The inclusion criteria for this study are patients with histologically proven BC; stage 1-3; aged >=18 years old; scheduled for adjuvant or neoadjuvant chemotherapy; Eastern Cooperative Oncology Group Performance Status from 0 to 1; able to communicate in Cantonese and read Chinese; available to be contacted by telephone.；
请登录查看The exclusion criteria are patients who are receiving treatment for mental disorders; diagnosis of cognitive impairment e.g., dementia; pregnancy; refused to participate; unable to communicate in Cantonese or read Chinese; illiterates; mentally incapacitated person.；
请登录查看香港中文大學醫學院那打素護理學院
/
求实药社2026-07-16
医药观澜2026-07-16
BioArt2026-07-16
一度医药2026-07-16
医药笔记2026-07-16
医药笔记2026-07-16
杏泽资本2026-07-16
药明康德2026-07-16
中国北京同仁堂官微2026-07-15
400-9696-311 转1
400-9696-311 转3
400-9696-311 转4
400-9696-311 转5
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
